Clinical Trial Update: Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update discusses the safety and efficacy of autologous adipose-derived mesenchymal stem cells (AD-MSC) and autologous adipose-derived hemato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Autologous adipose-derived hematopoietic stem cells (AD-HSC)
• Autologous adipose-derived mesenchymal stem cells (AD-MSC)

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Severe Aplastic Anemia | Phase 1, Phase 2 | Status: UNKNOWN